The analysis further revealed that MCU, alongside genes commonly mutated in breast cancer, demonstrated elevated expression levels comparable to key T cell regulators such as AHR, ID2, and TBFb1 (Fig. 7B). This evidence concerns the gene MCU and breast carcinoma.